•
Oct 31, 2013

Summit Therapeutics Q3 2013 Earnings Report

Total Revenue
$1.41M
Previous year: $643K
+118.8%
EPS
-$0.131
Previous year: -$0.0905
+44.3%
Gross Profit
$879K
Previous year: $249K
+253.4%

Summit Therapeutics

Summit Therapeutics